HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 608 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $271,010 | -81.3% | 2,635 | -88.8% | 0.01% | -84.0% |
Q3 2022 | $1,453,000 | -43.1% | 23,478 | -26.6% | 0.08% | -42.7% |
Q2 2022 | $2,553,000 | -20.5% | 32,004 | +4.9% | 0.13% | +7.4% |
Q1 2022 | $3,211,000 | +1.2% | 30,522 | +3.7% | 0.12% | +4.3% |
Q4 2021 | $3,172,000 | -9.1% | 29,439 | -7.6% | 0.12% | -7.9% |
Q3 2021 | $3,488,000 | +13.9% | 31,845 | -2.6% | 0.13% | +13.4% |
Q2 2021 | $3,061,000 | +1.8% | 32,684 | 0.0% | 0.11% | +2.8% |
Q1 2021 | $3,008,000 | -18.0% | 32,684 | -34.8% | 0.11% | -10.7% |
Q4 2020 | $3,667,000 | -92.6% | 50,124 | -92.2% | 0.12% | -94.0% |
Q3 2020 | $49,681,000 | +3.3% | 639,565 | -26.1% | 2.04% | -2.4% |
Q2 2020 | $48,071,000 | +32.5% | 864,890 | -29.4% | 2.10% | -0.2% |
Q1 2020 | $36,290,000 | -16.9% | 1,225,196 | +1.5% | 2.10% | +13.8% |
Q4 2019 | $43,691,000 | +32.9% | 1,206,934 | -0.1% | 1.84% | +20.1% |
Q3 2019 | $32,882,000 | +4.2% | 1,207,559 | -7.9% | 1.54% | +21.2% |
Q2 2019 | $31,545,000 | – | 1,311,078 | – | 1.27% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |